Based on the mechanism of neonatal hyperbilirubinemia treatment methods (light, exchange blood and drugs), three types of neonatal hyperbilirubinemia treatment mathematical models are established, and the expressions of the model solutions are given in this paper. By applying clinical test data and numerical approximation algorithm, the relevant parameters in the model can be estimated. According to the standards of "Expert Consensus", two treatment plans are designed, which are 1) the combined transfusion and phototherapy treatment plan and 2) the combined treatment plan of drugs, transfusion and phototherapy. The results of the program operation are numerically simulated and compared with the treatment data of clinical cases. It is found that the coincidence effect is important, which verified the rationality of the model. The model results can track and predict the changes of bilirubin levels in real-time, which provides a theoretical basis for the clinical design of treatment plans.
Citation: DongMei Li, Rui-xue Zhang, Qian Xie, Qi Wang. Mathematical model for treatment of neonatal hyperbilirubinemia[J]. Mathematical Biosciences and Engineering, 2021, 18(6): 8758-8782. doi: 10.3934/mbe.2021432
Based on the mechanism of neonatal hyperbilirubinemia treatment methods (light, exchange blood and drugs), three types of neonatal hyperbilirubinemia treatment mathematical models are established, and the expressions of the model solutions are given in this paper. By applying clinical test data and numerical approximation algorithm, the relevant parameters in the model can be estimated. According to the standards of "Expert Consensus", two treatment plans are designed, which are 1) the combined transfusion and phototherapy treatment plan and 2) the combined treatment plan of drugs, transfusion and phototherapy. The results of the program operation are numerically simulated and compared with the treatment data of clinical cases. It is found that the coincidence effect is important, which verified the rationality of the model. The model results can track and predict the changes of bilirubin levels in real-time, which provides a theoretical basis for the clinical design of treatment plans.
[1] | B. D. Gaqg, N. S Kabra, H. Balasubramanian, Role of massage therapy on reduction of neonatal hyperbilirubinemia in term and preterm neonates, a review of clinical trials, J. Matern.-Fetal Neonat. Med., 32 (2019), 301-309. |
[2] | V. K. Bhutani, A. Zipursky, H. Blencowe, R. Khanna, M. Sgro, F. Ebbesen, et al., Neonatal hyperbiliru-binemia and Rhesus disease of the newborn, incidence and impairment estimates for 2010 at regional and global levels, Pediatr. Res., 74 (2013), 86-100. |
[3] | J. E. Lawn, H. Blencowe, S. Oza, D. You, A. C. Lee, P. Waiswa, et al., Every newborn, progress, priorities and potential beyond survival, Lancet, 384 (2014), 189-205. |
[4] | J. Li, Application of metalloporphyrin to reduce bilirubin production in neonatal hyperbilirubinemia, J. Pediatr. Pharm., 20 (2014), 53-56. |
[5] | C. Y. Zhou, The effect of nursing intervention on blue light treatment of neonatal jaundice, Chin. Primary Med., 19 (2012), 638-639. |
[6] | Y. Ji, Application and related problems of phototherapy in neonates with hyperbilirubinemia, Int. J. Pediatr., 40 (2013), 272-274. |
[7] | Z. L. Peng, Comparative study on the efficacy and safety of intermittent and continuous blue light irradiation in the treatment of neonatal jaundice, Primary Med. Forum, 21 (2017), 4815. |
[8] | T. P. Vogl, T. Hegyi, I. M. Hiatt, Intermittent Phototherapy in the Treatment of Jaundice in the Premature Infant, J. Pediatr., 92 (1978), 627-630. doi: 10.1016/S0022-3476(78)80308-4 |
[9] | C. Q. Xu, J. Bai, G. U. Wei, Clinical effect of exchange blood therapy on neonatal hyperbilirubinemia, Med. Rev., 25 (2019), 3313-3316. |
[10] | X. X. Zuo, A. M. Xue, L. Na, Single and double circulating blood volume exchange transfusion for severe neonatal hyperbilirubinemia, J. Henan Univ. Sci. Technol. (Med. Ed.), 35 (2017), 129-131. |
[11] | L. X. Yang, X. L. Zheng, H. Y. He, Study on the effect of single and double blood transfusion on neonatal hyperbilirubinemia, Chongqing Med., 46 (2017). |
[12] | L. H. Long, L. Q. Li, J. L. Yu, Multi-factor analysis of the effects of exchange transfusion therapy on neonatal hyperbilirubinemia and the occurrence of adverse events, J. Pract. Pediatr., 14 (2011), 38-40. |
[13] | M. Ge, J. Tang, D. Z. Mu, Clinical study of the effect of exchange blood therapy and enhanced phototherapy on the nervous system of newborns with severe hyperindirect bilirubinemia, Chin. J. Neonatol., 34 (2019), 8-13. |
[14] | L. Y. Fan, Y. H. Xu, Research progress of neonatal bilirubin encephalopathy, J. Pediatr. Pharm., 22 (2016), 50-54 |
[15] | M. Shahian, M. A. Moslehi, Effect of albumin administration prior to exchange transfusion in term neonates with hyperbilirubinemia--a randomized controlled trial, Indian Pediatr., 47 (2010), 241-244. doi: 10.1007/s13312-010-0046-x |
[16] | M. Ge, J. Tang, Progress in treatment of neonatal severe hyperbilirub- inemia, Chin. J. Matern. Child Clin. Med. (Electr. Version), 14 (2016), 360-365. |
[17] | S. Thayyil, D. W. A. Milligan, Single versus double volume exchange transfusion in jaundiced newborn infants, Cochrane Data. Syst. Rev., 4 (2006), 4592. |
[18] | C. Q. Xu, J. Bai, G. U. Wei, Clinical Effects of Blood Exchange Therapy in Treatment of Neonatal Hyperbilirubinemia, Med. Recapitul., 25 (2019), 3315-3316. |
[19] | Z. P. Fang, Y. Lei, S. M. Wu, Phototherapy and its parameters for neonatal jaundice (review), J.Clin. Pediatr., 3 (1992), 196-198. |
[20] | X. H. Lu, Q. M. Meng, Parallel comparative study of intensive light therapy in the treatment of neonates with hyperbilirubinemia, Chin. Med. Sci., 18 (2017), 68-71. |
[21] | M. T. C. Ambat, E. M. Ostrea, J. V. Aranda, Effect of ibuprofen L-lysinate on bilirubin binding to albumin as measured by saturation index and horseradish peroxidase assays, J. Perinatol. Off. J. Californ. Perinat. Associat., 28 (2008), 287. |
[22] | Neonatology Group, Pediatrics Branch of Chinese Medical Association. Expert consensus on diagnosis and treatment of neonatal hyperbilirubinemia, Chin. J. Pediatr., 52 (2014), 745-748. |
[23] | H. M. Ye, K. L. Wei, Summary of the National Symposium on Neonatal Jaundice and Infection (with the recommended intervention plan for neonatal jaundice), Chin. J. Pediatr., 39 (2001), 184-185. |
[24] | C. M. Zhang, L. Z. Du, J. Yu, Determination of the correction factor of unbound photoisomer of bilirubin by high performance liquid chromatography and its clinical significance, J. Zhejiang Univ. (Med. Ed.), 29 (2000), 105-107. |
[25] | A. Knudsen, The Cephalocaudal Progression of Jaundice in Newborns in Relation to the Transfer of Bilirubin from Plasma to Skin, Early Human Dev., 22 (1990), 23-28. doi: 10.1016/0378-3782(90)90022-B |
[26] | Q. Y. Dai, Observation of the effect of intense light therapy and traditional light therapy on neonatal hyperbilirubinemia, Chongqing Med., 46 (2017), 1828. |
[27] | J. LI, Comparison of efficacy and safety of intense light therapy and traditional light therapy on neonatal hyperbilirubinemia, New Med. Knowl., (2019), 56-58. |
[28] | B. Y. Zhang, Analysis of dose-effect relationship and influencing factors of exchange transfusion therapy in neonates with hyperbilirubinemia, Guangxi Med. Univ., 2012. |
[29] | M. C. Chen, K. Cai, Analysis of the effect of blood exchange on the blood index of severe neonatal hyperbilirubinemia, Int. J. Laborat. Med., 8 (2013), 966-967. |
[30] | X. M. Shao, H. M. Ye, X. S. Qiu, Practical Neonatology (Fifth Edition), Beijing: People's Med. Publ. House, (2019), 112-446. |
[31] | A. Zorzi, S. Linciano, A. Angelini, Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics, Med. Chem. Commun., 10 (2019), 1068-1081 doi: 10.1039/C9MD00018F |
[32] | S. J. Huang, M. T. Li, R. Z. Chen, Dosage design for individualized admini- stration, New Med., 34 (2003), 21. |
[33] | M. L. Zhang, The effect of albumin on the treatment of hyperbilirubinemia by exchange blood transfusion, Hebei Med., 33 (2011), 2613-2614. |
[34] | X. P. Li, F. Wu, L. Chang, Transcutaneous bilirubin levels in the first 120 hour in term an neonates, J. Pediatr. Pharm., 19 (2013), 4-6. |